BioCryst to Present at Upcoming Investor Conference

BioCryst (Nasdaq:BCRX) will present at the Morgan Stanley 24th Annual Global Healthcare Conference in New York on Tuesday, September 15, 2026, at 9:15 a.m. ET.

Rhea-AI Summary

BioCryst (Nasdaq:BCRX) will present at the Morgan Stanley 24th Annual Global Healthcare Conference in New York on Tuesday, September 15, 2026, at 9:15 a.m. ET. A live audio webcast and replay will be available via the Investors & Media section of the company’s website.

Argus Sep 1 session 1 alert

+2.16% close to close 1.2x rel. volume Open Argus

Details

News Market Reaction – BCRX

$2.51B Mkt Cap at Peak Alert

On Sep 1, the day this news came out, BCRX closed 2.16% above the previous close.

Data tracked by StockTitan Argus for the Sep 1 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

RESEARCH TRIANGLE PARK, N.C., Sept. 01, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the Morgan Stanley 24^th Annual Global Healthcare Conference in New York on Tuesday, September 15, 2026, at 9:15 a.m. ET.

The link to the live audio webcast and replay of the presentation may be accessed in the Investors & Media section of BioCryst’s website at www.biocryst.com.

About BioCryst Pharmaceuticals

BioCryst is a global biotechnology company focused on developing and commercializing medicines for hereditary angioedema (“HAE”) and other rare diseases, driven by its deep commitment to improving the lives of people living with these conditions. BioCryst has commercialized ORLADEYO® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor and is advancing a pipeline of potential first-in-class or best-in-class therapeutics for rare diseases. For more information, please visit www.biocryst.com or follow us on LinkedIn.

BCRXW

Contact:

Investors:
investorrelations@biocryst.com

Media:
media@biocryst.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will BioCryst (BCRX) present at the Morgan Stanley 24th Annual Global Healthcare Conference?

BioCryst will present on Tuesday, September 15, 2026, at 9:15 a.m. ET. According to BioCryst, the presentation is part of the Morgan Stanley 24th Annual Global Healthcare Conference held in New York.

How can investors listen to BioCryst's (BCRX) September 15, 2026 conference presentation?

Investors can listen via a live audio webcast available on BioCryst’s website. According to BioCryst, access is through the Investors & Media section, where a replay of the presentation will also be posted.

Where on BioCryst's website will the BCRX conference webcast and replay be available?

The webcast and replay will be available in the Investors & Media section of www.biocryst.com. According to BioCryst, both the live audio and replay can be accessed from this investor-focused area.

What event is BioCryst (BCRX) participating in on September 15, 2026?

BioCryst is participating in the Morgan Stanley 24th Annual Global Healthcare Conference in New York. According to BioCryst, the company plans to deliver a presentation with live audio webcast access for investors.

Will a replay of BioCryst's (BCRX) Morgan Stanley healthcare conference presentation be available?

Yes, a replay of the presentation will be available after the event. According to BioCryst, investors can access the replay via the Investors & Media section of the company’s official website, www.biocryst.com.